New England Biolabs (United States)
New England Biolabs, Inc. is an American life sciences company which produces and supplies recombinant and native enzyme reagents for life science research. It also provides products and services supporting genome editing, synthetic biology and next-generation sequencing. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for New England Biolabs (United States), United States, covering academic research published from 2000 to 2025. Read More.
Open Access Percentage
70%
Total
Publications
2.4K
Total Open
Publications
1.7K
Total
Citations
144K
Open Access
Percentage
70%
Total
Publications
2.4K
Total Open
Publications
1.7K
Total
Citations
144K
Breakdown
Publisher Open
13%
Both
42%
Other Platform Open
14%
Closed
31%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 67%
874
Hybrid 15%
193
No Guarantees 18%
237
Other Platform Open
Domain 80%
1.1K
Institution 40%
541
Preprint 13%
173
Public 6%
81
Other Internet 5%
67
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 1.1K |
doaj.org OAI-PMH Repository | Institution | 328 |
bioRxiv | Preprint | 138 |
Figshare | Public | 81 |
Office of Scientific and Technical Information | Institution | 64 |
Harvard University | Institution | 64 |
Europe PMC | Domain | 59 |
DOI | Other Internet | 55 |
National Institutes of Health | Institution | 26 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 24 |